Systemic autoimmune diseases co-existing with chronic hepatitis C virus infection (the HISPAMEC Registry): Patterns of clinical and immunological expression in 180 cases

Journal of Internal Medicine

Volumn 257, Issue 6, 2005, Pages 549-557

  Ramos Casals, Manuel ^a,h   Jara, L J ^b   Medina, F ^c   Rosas, J ^d   Calvo Alen, J ^e   Mana J ^f   Anaya, J M ^g   Font, J ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c HOSPITAL DE ESPECIALIDADES   (Mexico)

^d Hospital de la Vila Joiosa   (Spain)

^e HOSPITAL SIERRALLANA   (Spain)

^f HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^g UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

^h HOSPITAL CLÍNIC   (Spain)

Author keywords

Antiphospholipid syndrome; Hepatitis C virus; Lymphoma; Polyarteritis nodosa; Rheumatoid arthritis; Sj gren's syndrome; Systemic lupus erythematosus

Indexed keywords

ANTINUCLEAR ANTIBODY; CRYOGLOBULIN; RHEUMATOID FACTOR;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; AUTOIMMUNE DISEASE; CHRONIC HEPATITIS; COMORBIDITY; CRYOGLOBULINEMIA; DISEASE CLASSIFICATION; FEMALE; HEPATITIS C; HUMAN; HYPOCOMPLEMENTEMIA; MAJOR CLINICAL STUDY; MALE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANTIBODIES, ANTINUCLEAR; ANTIPHOSPHOLIPID SYNDROME; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; COMPLEMENT SYSTEM PROTEINS; CRYOGLOBULINEMIA; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOMA; MALE; MIDDLE AGED; POLYARTERITIS NODOSA; RHEUMATOID FACTOR; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC; VASCULITIS;

EID: 20144375711     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2005.01490.x     Document Type: Article

References (45)

1. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-62.
2. Alter MJ, Mast EE. The epidemiology of viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23: 437-55.
3. Yen T, Keeffe EB, Ahmed A. The epidemiology of hepatitis C virus infection. J Clin Gastraenterol 2003; 36: 47-53.
4. Alter MJ, Kruszon-Moran D, Nainan OV et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
5. Glynn SA, Kleinman SH, Schreiber GB et al. Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS). JAMA 2000; 284: 229-35.
6. Cumber SC, Chopra S. Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20.
7. Ramos-Casals M, Garcia-Carrasco M, Cervera R et al. Hepatitis C virus infection mimicking primary Sjogren syndrome. A clinical and immunologic description of 35 cases. Medicine (Baltimore) 2001; 80: 1-8.
8. Lovy MR, Starkebaum G, Uberoi S. Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996; 23: 979-83.
9. Perlemuter G, Cacoub P, Sbai A et al. Hepatitis C virus infection in systemic lupus erythematosus: a case-control study. J Rheumatol 2003; 30: 1473-8.
10. Ramos-Casals M, Font J, Garcia-Carrasco M et al. Hepatitis C virus infection mimicking systemic lupus erythematosus: study of hepatitis C virus infection in a series of 134 Spanish patients with systemic lupus erythematosus. Arthritis Rheum 2000; 43: 2801-6.
11. Trejo O, Ramos-Casals M, Garcia-Carrasco M et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine (Baltimore) 2001; 80: 252-62.
12. Vitali C, Bombardieri S, Moutsopoulos HM et al. Preliminary criteria for the classification of Sjogren's syndrome. Arthritis Rheum 1993; 36: 340-7.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
14. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
15. Anonymous. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee. Arthritis Rheum 1980; 23: 581-90.
16. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975; 292: 344-47.
17. Wilson WA, Gharavi AE, Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum 1999; 42: 1309-11.
18. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-94.
19. Cacoub P, Renou C, Rosenthal E et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. Medicine (Baltimore) 2000; 79: 47-56.
20. Buskila D, Shnaider A, Neumann L et al. Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998; 28: 107-13.
21. DeVita S, Damato R, De Marchi G, Sacco S, Ferraccioli G. True primary Sjogren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. Isr Med Assoc J 2002; 4: 1101-5.
22. Rivera J, Garcia-Monforte A. Hepatitis C virus infection presenting as rheumatoid arthritis. Why not?. J Rheumatol 1999: 26: 2062-3.
23. Ramos-Casals M, Font J, Ingelmo M. Prevalence and clinical significance of hepatitis C virus infection in systemic autoimmune diseases. Med Clin (Barc) 2001; 116: 701-9.
24. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Immunological features and HLA associations in chronic viral hepatitis. Gastroenterology 1995; 108: 157-64.
25. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19: 841-8.
26. Verbaan H, Carlson J, Eriksson S et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjogren's syndrome and hepatitis C in Swedish patients. J Intern Med 1999; 245: 127-32.
27. Barrett S, Goh J, Coughlan B et al. The natural course of hepatitis C virus infection after 22 years in a unique homogenous cohort: spontaneous viral clearance and chronic HCV infection. Gut 2001; 49: 423-30.
28. Lamprecht P, Gause A, Gross WL. Cryoglobulinemic vasculitis. Arthritis Rheum 1999; 42: 2507-16.
29. Tzioufas AG, Boumba DS, Skopouli FN, Moutsopoulos HM. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor cross-reactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum 1996; 39: 767-72.
30. George J, Shoenfeld Y. The immune system, the autoimmune state and autoimmune disease. In: Shoenfeld Y, Gershwin E, eds, Cancer and Autoimmunity, Amsterdam, the Netherlands: Elsevier, 2000: 1-19.
31. Silvestri F, Pipan C, Barillari G et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood 1996; 87: 4296-301.
32. Ramos-Casals M, Font J, Garcia-Carrasco M et al. Primary Sjogren syndrome: hematologic patterns of disease expression. Medicine (Baltimore) 2002; 81: 281-92.
33. Cervera R, Khamashta MA, Font J et al. Euro-Lupus Project: 10-year prospective study of morbidity and mortality in a cohort of 1000 patients with SLE. Arthritis Rheum 2002; 46: S262-3.
34. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male veterans. Hepatology 2002; 36: 1439-45.
35. Mariette X. Lymphomas complicating Sjogren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Ann Rheum Dis 2001; 60: 1007-10.
36. Ramos-Casals M, García-Carrasco M, Font J, Cervera R. Sjögren's syndrome and lymphoproliferative disease. In: Shoenfeld Y, Gershwin E, eds. Cancer and Autoimmunity. Amsterdam, the Netherlands: Elsevier, 2000: 55-80.
37. Ioannidis JP, Vassiliou VA, Moutsopoulos HM. Long-term risk of mortality and lymphoproliferative disease and predictive classification of primary Sjogren's syndrome. Arthritis Rheum 2002; 46: 741-7.
38. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjogren's syndrome: a prospective cohort study. Arthritis Rheum 2004; 50: 1262-9.
39. Ramos-Casals M, Brito-Zeron P, Yague J et al. Hypocomplementaemia as an immunological marker of morbidity and mortality in patients with primary Sjogren's syndrome. Rheumatology (Oxford) 2005; 44: 89-94.
40. Ramos-Casals M, Trejo O, Garcia-Carrasco M, Font J. Therapeutic management of extrahepatic manifestations in patients with chronic hepatitis C virus infection. Rheumatology (Oxford) 2003; 42: 818-28.
41. Zuckerman E, Keren D, Slobodin G et al. Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha. J Rheumatol 2000; 27: 2172-8.
42. Bruchfeld A, Lindahl K, Stahle L, Soderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepatitis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant 2003; 18: 1573-80.
43. Emens LA, Sulkowski MS. Regression of splenic lymphoma after treatment of hepatitis C virus infection. N Engl J Med 2002; 347: 2168-70.
44. Levine AM, Shimodaira S, Lai MM. Treatment of HCV-related mantle-cell lymphoma with ribavirin and pegylated interferon Alfa. N Engl J Med 2003; 349: 2078-9.
45. Tursi A, Brandimarte G, Torello M. Disappearance of gastric mucosa-associated lymphoid tissue in hepatitis C virus-positive patients after anti-hepatitis C virus therapy. J Clin Gastroenterol 2004; 38: 360-3.